January 13, 2017 — Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (OCT) ...
Stents Drug Eluting
This channel includes news and new technology innovations for drug eluting stents (DES). These drug coated stents were developed to solve a frequent problem with bare metal stents, which can cause neointimal hyperplasia (scar tissue growth) in some patients. The antiproliferative drugs used on DES prevent the growth of tissue. One downside of DES is the requirement for patients to take long-term antiplatelet therapy to prevent the possible formation of clots on these stents. Newer generation DES use technologies help the vessels heal faster, which may allow reduce the duration of dual antiplatelet therapy (DAPT), or use a single drug, usually eliminating aspirin. This section includes news for both metallic and bioresorbable drug-eluting stents and related clinical trial data.
The biggest news from the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting this past fall was the results of ...
January 10, 2017 — Medinol announced in December positive twelve-month clinical results from the BIONICS study. The ...
November 9, 2016 — A dedicated stent study conducted exclusively in women and minority patients evaluated clinical ...
November 9, 2016 – Results from a randomized, multicenter trial failed to show non-inferiority of hybrid, ultra-thin ...
Juan Granada, M.D., executive director and chief scientific officer of the Cardiovascular Research Foundation's Skirball ...
David Kandzari, M.D., director of interventional cardiology and chief scientific officer, Piedmont Heart Institute ...
November 7, 2016 – Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (OCT) ...
November 7, 2016 – The two-year results from LEADERS FREE, the first randomized clinical trial dedicated to high ...
November 7, 2016 – The large multinational randomized BIONICS study found that a novel elastic polymer coated ...
November 2, 2016 — Investigators recently unveiled clinical data from the independent BIO-RESORT study, representing the ...
November 1, 2016 — Medtronic plc unveiled the first clinical outcomes of its novel Drug-Filled Stent (DFS) from the ...
October 31, 2016 — Micell Technologies Inc. announced that it presented five-year clinical safety and efficacy results ...
October 31, 2016 — A major international study has found that drug-eluting stents, a less-invasive alternative to bypass ...
September 28, 2016 — The Cardiovascular Research Foundation (CRF) included 11 late-breaking trials and 16 first report ...